Magnetic Resonance Imaging of Cardiovascular Manifestations Following COVID-19.
Felipe Sanchez TijmesConstantin MarschnerPaaladinesh ThavendiranathanKate HannemanPublished in: Journal of magnetic resonance imaging : JMRI (2023)
Globally, over 650 million people have had COVID-19 due to infection with the SARS-Cov-2 virus. Cardiac complications in the acute infectious and early recovery phase were recognized early in the pandemic, including myocardial injury and inflammation. With a decrease in the number of acute COVID-19 related deaths, there has been increased interest in postacute sequela of COVID-19 (PASC) and other longer-term cardiovascular complications. A proportion of patients recovered from COVID-19 have persistent cardiac symptoms and are at risk of cardiovascular disease. Cardiovascular imaging, including MRI, plays an important role in the detection of cardiovascular manifestations of COVID-19 in both the acute and longer-term phases after COVID-19. The purpose of this review is to highlight the role of cardiovascular imaging in the diagnosis and risk stratification of patients with acute and chronic cardiovascular manifestations of COVID-19 with a focus on cardiac MRI. EVIDENCE LEVEL: 4. TECHNICAL EFFICACY: Stage 3.
Keyphrases
- sars cov
- coronavirus disease
- magnetic resonance imaging
- respiratory syndrome coronavirus
- cardiovascular disease
- liver failure
- left ventricular
- high resolution
- drug induced
- type diabetes
- end stage renal disease
- oxidative stress
- magnetic resonance
- risk factors
- newly diagnosed
- respiratory failure
- hepatitis b virus
- peritoneal dialysis
- gestational age
- ejection fraction
- cardiovascular events
- fluorescence imaging
- patient reported outcomes
- mechanical ventilation
- label free